health
US FDA Approves World's First Oral Cholesterol-Lowering Pill
Archived — last updated
The US Food and Drug Administration has approved Lipfendra, the world's first oral PCSK9 inhibitor, for adults with high cholesterol. The once-daily pill is designed to significantly reduce low-density lipoprotein (LDL) or bad cholesterol.
Latest updates
US FDA Approves World's First Oral Cholesterol-Lowering Pill
The US Food and Drug Administration has approved Lipfendra, the world's first oral PCSK9 inhibitor, for adults with high cholesterol. The once-daily pill is designed to significantly reduce low-density lipoprotein (LDL) or bad cholesterol. Patients with difficult-to-control high cholesterol may soon have an alternative to injectable cholesterol-lowering drugs. The approval of Lipfendra is a significant development in the treatment of high cholesterol, and it is expected to provide relief to millions of patients worldwide.
Sources
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.